D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
批准号:
2890625
负责人:
BETH LEVANT
金额:
$10.85万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-01 至 2001-03-31
关键词:
6 hydroxydopamine antipsychotic agents autoradiography brain metabolism cerebellum dopamine dopamine agonists dopamine antagonists dopamine receptor drug receptors experimental brain lesion gene expression glucose metabolism high performance liquid chromatography in situ hybridization innervation laboratory rat limbic system microinjections neuroanatomy neurochemistry neuropharmacology receptor binding receptor expression receptor sensitivity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The D3 dopamine
receptor is a novel receptor which has been implicated as a potential
therapeutic target in the treatment of schizophrenia.This proposal
addresses the issue of whether the D3 receptor mediates any of the
therapeutic and/or side-effects of antipsychotic drugs. The hypothesis
is that D3 receptors in limbic brain regions may mediate the therapeutic
effects of antipsychotic drugs, while cerebellar D3 receptors may
mediate certain neurological side-effects. Molecular, biochemical,
pharmacological, anatomical, and behavioral approaches will be used to
address the specific aims: (1) to determine how D3 receptors are
regulated by tonic dopaminergic activity. The effects of unilateral and
bilateral 6-OHDA lesions of the major dopamine projections on the density
of D3 receptors and mRNA indiscrete brain regions will be examined using
receptor autoradiography, receptor binding, and in situ hybridization.
(2) to determine how D3 receptors are regulated by dopamine agonists and
antagonists using receptor autoradiography, receptor binding, and in situ
hybridization. (3) to determine D3 receptor occupation by antipsychotic
drugs in vivo using receptor autoradiography. (4) to determine the
effects of D3 receptor stimulation or blockade on neuronal activity in
specific brain regions by assessment of (a) Fos expression and (b)
cerebral glucose utilization. (5) to determine whether cerebellar D3
receptors have dopaminergic innervation and, if so, the source.
Autoradiographic methods, measurement of catecholamines by HPLC-EC, and
retrograde tracers will be used. (6) to determine whether cerebellar
dopamine receptors are present in humans and other mammalian species
using receptor autoradiography and in situ hybridization. (7) to
determine the behavioral effects of microinjection of dopamine agonists
and antagonists into cerebellar lobule 10. These studies will provide
significant information regarding the functional role of D3 receptor, its
potential involvement in the effects of antipsychotic drugs, and its
suitability as a therapeutic target.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride.
D3 多巴胺受体选择性剂量的 7-OH-DPAT 和 nafadotride 引起局部脑葡萄糖利用的改变。
DOI:
10.1016/s0006-8993(98)00924-x
发表时间:
1998
期刊:
Brain research
影响因子:
2.9
作者:
[Levant,B, Cross,RS, Pazdernik,TL]
通讯作者:
Pazdernik,TL
Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
[3H]PD 128907(一种假定的 D3 多巴胺受体选择性配体)在大鼠脑中的结合:受体结合和定量放射自显影研究。
DOI:
10.1016/s0893-133x(97)00162-0
发表时间:
1998
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
[Bancroft,GN, Morgan,KA, Flietstra,RJ, Levant,B]
通讯作者:
Levant,B
Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
7-OH-DPAT 和 nafadotride 诱导大鼠纹状体和伏核中神经降压素原/神经调节素 N mRNA 水平增加。
DOI:
10.1016/s0893-133x(99)00033-0
发表时间:
1999
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
[Levant,B, Garimelli,B, Shafer,RA, Merchant,KM]
通讯作者:
Merchant,KM
In vivo occupancy of D2 dopamine receptors by nafadotride.
nafadotride 体内 D2 多巴胺受体的占据。
DOI:
10.1016/s0893-133x(97)00024-9
发表时间:
1997
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
[Levant,B, Vansell,NR]
通讯作者:
Vansell,NR
N-3 Fatty Acids: Roles in Parkinson's Disease
-
批准号:8071047
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2010
-
负责人:BETH LEVANT
-
依托单位:
N-3 Fatty Acids: Roles in Parkinson's Disease
-
批准号:7988494
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2010
-
负责人:BETH LEVANT
-
依托单位:
N-3 Fatty Acids and Outcomes in Pediatric Traumatic Brain Injury
-
批准号:7570325
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:BETH LEVANT
-
依托单位:
N-3 Fatty Acids and Outcomes in Pediatric Traumatic Brain Injury
-
批准号:7751876
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:BETH LEVANT
-
依托单位:
Brain LC-PUFAs and Maternal Mental Health
-
批准号:6812717
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
Brain DHA, Dopamine, and Behavior: Roles in ADHD
-
批准号:6954210
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
Brain LC-PUFAs and Maternal Mental Health
-
批准号:7091557
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
Brain DHA, Dopamine, and Behavior: Roles in ADHD
-
批准号:6868246
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
Brain LC-PUFAs and Maternal Mental Health
-
批准号:6949129
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
Brain DHA, Dopamine, and Behavior: Roles in ADHD
-
批准号:7091446
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2004
-
负责人:BETH LEVANT
-
依托单位:
D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
-
批准号:2675245
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:BETH LEVANT
-
依托单位:
D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
-
批准号:2392964
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1995
-
负责人:BETH LEVANT
-
依托单位:
D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
-
批准号:2252763
-
项目类别:
-
资助金额:$9.65万
-
财政年份:1995
-
负责人:BETH LEVANT
-
依托单位:
D3 DOPAMINE RECEPTORS--POTENTIAL ANTIPSYCHOTIC TARGET
-
批准号:2252762
-
项目类别:
-
资助金额:$10.86万
-
财政年份:1995
-
负责人:BETH LEVANT
-
依托单位:
海外基金